Abstract：
:The structure of 'stabilized plasmid-lipid particles' (SPLP) and their properties as systemic gene therapy vectors has been investigated. We show that SPLP can be visualized employing cryo-electron microscopy to be homogeneous particles of diameter 72 +/- 5 nm consisting of a lipid bilayer surrounding a core of plasmid DNA. It is also shown that SPLP exhibit long circulation lifetimes (circulation half-life >6 h) following intravenous (i.v.) injection in a murine tumor model resulting in accumulation of up to 3% of the total injected dose and concomitant reporter gene expression at a distal (hind flank) tumor site. In contrast, i v. injection of naked plasmid DNA or plasmid DNA-cationic liposome complexes did not result in significant plasmid delivery to the tumor site or gene expression at that site. Furthermore, it is shown that high doses of SPLP corresponding to 175 microg plasmid per mouse are nontoxic as assayed by monitoring serum enzyme levels, whereas i.v. injection of complexes give rise to significant toxicity at dose levels above 20 microg plasmid per mouse. It is concluded that SPLP exhibit properties consistent with potential utility as a nontoxic systemic gene therapy vector.
journal_name
Gene Therjournal_title
Gene therapyauthors
Tam P,Monck M,Lee D,Ludkovski O,Leng EC,Clow K,Stark H,Scherrer P,Graham RW,Cullis PRdoi
10.1038/sj.gt.3301308keywords:
subject
Has Abstractpub_date
2000-11-01 00:00:00pages
1867-74issue
21eissn
0969-7128issn
1476-5462journal_volume
7pub_type
杂志文章相关文献
GENE THERAPY文献大全abstract：:This study was designed to evaluate the utility of positron emission tomography (PET) to quantify the magnitude and spatial distribution of transgene expression after different methods of adenoviral vector delivery (with surfactant- and saline-based vehicles) within rat lungs. In all, 17 animals (eight in the surfacta...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302117
更新日期：2003-12-01 00:00:00
abstract：:Adeno-associated virus (AAV) gene therapy constitutes a powerful tool for the treatment of neurodegenerative diseases. While AAVs are generally administered systemically to newborns in preclinical studies of neurological disorders, in adults the maturity of the blood-brain barrier (BBB) must be considered when selecti...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2017.18
更新日期：2017-05-01 00:00:00
abstract：:Replication defective vectors derived from simple retroviruses or the more complex genomes of lentiviruses continue to offer the advantages of long-term expression, cell and tissue specific tropism, and large packaging capacity for the delivery of therapeutic genes. The occurrence of adverse events caused by insertion...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/sj.gt.3302570
更新日期：2005-07-01 00:00:00
abstract：:The proteasome is a multisubunit cytosolic protein complex responsible for degrading cytosolic proteins. Several studies have implicated its involvement in the processing of viral particles used for gene delivery, thereby limiting the efficiency of gene transfer. Peptide-based nonviral gene delivery systems are suffic...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302575
更新日期：2005-11-01 00:00:00
abstract：:To facilitate the understanding of the complex process of target gene expression and its control, we report a modified inducible system for activation or repression of target gene expression in response to an exogenously administered compound. The main component of this inducible system is a chimeric transcriptional a...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300402
更新日期：1997-05-01 00:00:00
abstract：:Neonatal AAV8-mediated Factor IX (F.IX) gene delivery was applied as a model for exploring mechanisms of tolerance induction during immune ontogeny. Intraperitoneal delivery of AAV8/ Factor IX (hF.IX) during weeks 1-4 of life, over a 20-fold dose range, directed stable hF.IX expression, correction of coagulopathy in F...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2013.22
更新日期：2013-10-01 00:00:00
abstract：:Viral gene vectors often rely on packaging cell lines, which provide the necessary factors in trans for the formation of virus-like particles. Previously, we reported on a first-generation packaging cell line for gene vectors, which are based on the B-lymphotropic Epstein-Barr virus (EBV), a human gamma-herpesvirus. T...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302714
更新日期：2006-05-01 00:00:00
abstract：:Regulated gene delivery systems are usually made of two elements: an inducible promoter and a transactivator. In order to optimize gene delivery and regulation, a single viral vector ensuring adequate stoichiometry of the two elements is required. However, efficient regulation is hampered by interferences between the ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301838
更新日期：2003-01-01 00:00:00
abstract：:We have constructed two recombinant adeno-associated virus (AAV) vectors (pJJ-3GC and pJJ-3ASA) which contained either the human glucocerebrosidase (GC) or arylsulfatase A (ASA) cDNA under the control of an SV40 promoter. These plasmids were co-transfected to 293 cells with a helper plasmid containing trans-acting AAV...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1994-07-01 00:00:00
abstract：:Different lipids and cationic polymers were tested in vitro for their ability to transfect rabbit aortic smooth muscle cells and human endothelial cells with lacZ marker gene. Toxicity of the complexes was evaluated with MTT assay. Selected plasmid-polymer complexes with different charge ratios were then tested for in...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300800
更新日期：1999-01-01 00:00:00
abstract：:A stable single vial lipoplex formulation has been developed that can be stored frozen without losing either biological activity or physical stability. This formulation was identified by systematically controlling several formulation variables and without introducing either stabilizers or surfactants. Analytical assay...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300707
更新日期：1998-09-01 00:00:00
abstract：:Episomally maintained self-replicating systems present attractive alternative vehicles for gene therapy applications. Recent insights into the ability of chromosomal scaffold/matrix attachment regions (S/MARs) to mediate episomal maintenance of genetic elements allowed the development of a small circular episomal vect...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302593
更新日期：2006-01-01 00:00:00
abstract：:We tested the influence of overexpression of arylsulfatase A (ASA) on the activity of other sulfatases in fibroblasts from patients with metachromatic leukodystrophy (MLD). We demonstrated that the overexpression of ASA reduces the activity of various sulfatases by a small amount but does not induce an accumulation of...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1995-08-01 00:00:00
abstract：:Deficiency in acid alpha-D-glucosidase results in Pompe's disease. Modified single-stranded oligonucleotide (ODN) was designed to correct the acid alpha-D-glucosidase gene with a C1935 --> A (Asp --> Glu) point mutation which causes a complete loss of enzymatic activity for glycogen digestion in the lysosome. The ODN ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302096
更新日期：2003-10-01 00:00:00
abstract：:Somatic gene transfer to the pulmonary endothelium may be a useful strategy for modifying the phenotype of endothelium and/or vascular smooth muscle in disorders such as primary pulmonary hypertension, ARDS or pulmonary metastatic disease. Adenoviral (Ad) vectors, although highly efficient in liver gene transfer, have...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301636
更新日期：2002-02-01 00:00:00
abstract：:We have developed and tested a transfection compound based on synthetic peptides. It consists of a 12 amino acid DNA binding peptide (P2) with an alkyl group added to the aminoterminus (P2lip) and a peptide derived from the hemagglutinin protein (HA). The components aggregate spontaneously to particles that proved to ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1996-12-01 00:00:00
abstract：:The mouse is widely used as a model for DNA therapy and vaccination even though the efficiency of DNA delivery in higher mammals and humans is much less. The human APOBEC3 (A3) enzymes impact viral genomes by cytidine deamination, which introduces multiple uridine residues into single-stranded DNA, a process known as ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2014.88
更新日期：2015-01-01 00:00:00
abstract：:Alphavirus vectors based on Sindbis virus and Semliki Forest virus (SFV) were characterized as potential gene transfer vectors. Initial studies were performed using vectors engineered to transfer either lacZ or green fluorescent protein (GFP). High levels of gene transfer were achieved in human primary fibroblasts, BH...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301122
更新日期：2000-03-01 00:00:00
abstract：:We have developed a retroviral vector coexpressing the multidrug-resistance 1 (MDR1) cDNA for inducing cancer drug resistance and the truncated version of the low-affinity nerve growth factor receptor (DeltaLNGFR) for cell-surface marking of transduced cells. The vector is based on the FMEV backbone which mediates hig...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300942
更新日期：1999-07-01 00:00:00
abstract：:Mutations in GJB2, which codes for the gap junction (GJ) protein connexin26 (Cx26), are the most common causes of human nonsyndromic hereditary deafness. We inoculated modified adeno-associated viral (AAV) vectors into the scala media of early postnatal conditional Gjb2 knockout mice to drive exogenous Cx26 expression...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2013.59
更新日期：2014-01-01 00:00:00
abstract：:Growth factor therapy is an emerging treatment modality that enhances tissue vascularization, promotes healing and regeneration and can treat a variety of inflammatory diseases. Both recombinant human growth factor proteins and their gene therapy are in human clinical trials to heal chronic wounds. As platelet-derived...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2009.60
更新日期：2009-09-01 00:00:00
abstract：:We have compared the efficacy of daily injection of recombinant leptin protein (rh-leptin) with adenovirus-mediated delivery of the murine or human leptin gene (Ad-leptin) for treatment of obesity in the obese (ob/ob) mouse model. We demonstrate an improved correction profile for obesity and associated surrogate marke...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300565
更新日期：1998-01-01 00:00:00
abstract：:Silencing of gene expression by small interfering RNAs (siRNAs) is rapidly becoming a powerful tool for genetic analysis of mammalian cells. The use of DNA-based plasmid vectors to achieve transient and stable expression of siRNA has been developed to avoid the problems of double-stranded oligonucleotides transfection...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302878
更新日期：2007-03-01 00:00:00
abstract：:Adoptive immunotherapy of cancer using chimeric antigen receptor (CAR)-engineered T cells with redirected specificity showed efficacy in recent trials. In preclinical models, 'second-generation' CARs with CD28 costimulatory domain in addition to CD3ζ performed superior in redirecting T-cell effector functions and surv...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2010.127
更新日期：2011-01-01 00:00:00
abstract：:Inadequate antiprotease activity in the lungs due to alpha-1-antitrypsin (A1AT) deficiency is a factor of early-onset emphysema. We propose a new approach to gene therapy that involves the intratracheal delivery of macrophages expressing human A1AT (hA1AT). Recombinant adeno-associated virus (rAAV) plasmids encoding t...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302121
更新日期：2003-12-01 00:00:00
abstract：:Glioblastoma multiforme (GBM) is one of the most formidable brain tumors with a mean survival period of approximately 12 months. To date, a combination of radiotherapy and chemotherapy with an oral alkylating agent, temozolomide (TMZ), has been used as first-line therapy for glioma. However, the efficacy of chemothera...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2010.88
更新日期：2010-11-01 00:00:00
abstract：:The potential for gene therapy to be an effective treatment for cystic fibrosis has been hampered by the limited gene transfer efficiency of current vectors. We have shown that recombinant Sendai virus (SeV) is highly efficient in mediating gene transfer to differentiated airway epithelial cells, because of its capaci...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302991
更新日期：2007-10-01 00:00:00
abstract：:Synthetic oligonucleotides and DNA fragments of less than 1 kilobase (kb) have been shown to cause site-specific genetic alterations in mammalian cells in culture and in vivo. We have used a lacZ reporter gene system to compare the efficiency of episomal and chromosomal gene repair in human embryonic kidney epithelial...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302049
更新日期：2003-09-01 00:00:00
abstract：:Transplantation faces several major obstacles that could be overcome by expression of immunomodulatory proteins through application of gene therapy techniques. Gene therapy strategies to prolong graft survival involve gene transfer of immunosuppressive or graft-protecting molecules. Very promising results have been ob...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/sj.gt.3301083
更新日期：2000-01-01 00:00:00
abstract：:Apo(a) is a very atherogenic plasma protein without apparent function, which is highly expressed in humans. The variation in plasma Lp(a) concentration among individuals is considerable. Approximately 10-15% of the white population exhibit plasma Lp(a) concentrations above the atherogenic cut-off value of approximatel...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301434
更新日期：2001-03-01 00:00:00
